Shigella Vaccines

Actionable Insights Powered by AI

Valneva Invests $10M in LimmaTech for Clinical-Stage Shigella Vaccine

Valneva, LimmaTech, Shigella vaccine, clinical-stage, biotech, pharmaceuticals, vaccine development